Published in
Wiley, Alimentary Pharmacology and Therapeutics, 2(47), p. 259-267
DOI: 10.1111/apt.14423
Links
Tools
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3
Journal article published in 2017 by
Z. M. Younossi 
,
M. Stepanova,
I. M. Jacobson,
T. Asselah ,
E. J. Gane,
E. Lawitz,
G. R. Foster ,
S. K. Roberts ,
A. J. Thompson,
B. E. Willems,
T. M. Welzel,
B. Pearlman,
I. Younossi,
A. Racila,
L. Henry
,
M. Stepanova,
I. M. Jacobson,
T. Asselah ,
E. J. Gane,
E. Lawitz,
G. R. Foster ,
S. K. Roberts ,
A. J. Thompson,
B. E. Willems,
T. M. Welzel,
B. Pearlman,
I. Younossi,
A. Racila,
L. Henry
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 